NCT05835349View on ClinicalTrials.gov

Observational Study of Venus P-Valve

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2032

Conditions
Right Ventricular Outflow Tract Dysfunction
Interventions
DEVICE

transcatheter pulmonary valve implantation (TPVI)

A stent-mounted valve is introduced over a guidewire and positioned in the RVOT, followed by balloon inflation to deploy the valve.

Trial Locations (10)

165

NOT_YET_RECRUITING

OPBG Rome, Rome

13353

NOT_YET_RECRUITING

Clinic of Congenital Heart Disease, Berlin

20097

NOT_YET_RECRUITING

S. Donato Milan, Milan

33600

NOT_YET_RECRUITING

CHU Bordeaux, Pessac

44093

RECRUITING

Chu Nantes, Nantes

75015

RECRUITING

Hopital Necker-Enfants malades, Paris

81377

NOT_YET_RECRUITING

Heart CenterMunich, Munich

92350

RECRUITING

Marie Lannelongue, Le Plessis-Robinson

LS1 3EX

NOT_YET_RECRUITING

Leeds General Infirmary, Leeds

SE1 7EH

NOT_YET_RECRUITING

Evelina Children's Hospital, London

All Listed Sponsors
collaborator

IQVIA MedTech BV of Antwerp, Belgium

UNKNOWN

collaborator

MDCECRO LLC

NETWORK

lead

Venus MedTech (HangZhou) Inc.

INDUSTRY